Physician profile
Faruk Ali
NPI 1093024499
$1,001.39
in general payments reported to CMS, 2019-2025
25 companies · $77.68 in 2025
The $77.68 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $172 · 2022: $260 · 2023: $185 · 2024: $307 · 2025: $77.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $182.20 | 2023-2025 | Watchman Flx, Ams 700 |
| Novo Nordisk INC | $157.10 | 2022-2024 | Wegovy |
| Abbvie INC. | $136.39 | 2022-2024 | |
| Philips North America LLC | $74.75 | 2021-2024 | (Ck7) Extended Holter |
| Bayer Healthcare Pharmaceuticals INC. | $63.90 | 2021-2024 | |
| Mylan Specialty L.P. | $52.04 | 2022-2024 | Yupelri |
| Lilly USA, LLC | $29.94 | 2022-2025 | Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.11 | 2021-2022 | |
| Redhill Biopharma INC. | $24.70 | 2021 | |
| Amgen INC. | $23.72 | 2021 | |
| Inspire Medical Systems, INC. | $21.03 | 2025 | Inspire |
| Biotronik Nro, INC. | $19.00 | 2024 | Prospera |
| Althera Pharmaceuticals LLC | $16.78 | 2022 | |
| Exact Sciences Corporation | $15.44 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $15.00 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $14.96 | 2022 | |
| Genentech USA, INC. | $14.92 | 2021 | |
| Ferring Pharmaceuticals INC. | $14.72 | 2021 | |
| Pfizer INC. | $14.71 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.40 | 2022 | |
| Intra-Sana Laboratories | $14.06 | 2024 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Biohaven Pharmaceuticals, INC. | $13.85 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.16 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.77 | 2022 | |
| Nestle Healthcare Nutrition INC. | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faruk Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.